| 英文别名 |
6β-Hydroxy Norgestrel;6β-Hydroxylevonorgestrel;(6R,8R,9S,10R,13R,14S,17R)-13-ethyl-17-ethynyl-6,17-dihydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one;13-Ethyl-6beta,17-dihydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one (6beta-Hydroxylevonorgestrel);(6R,8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-6,17-dihydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one;UNII-Y643AOR6HN;(6beta,17alpha)-(+/-)-13-Ethyl-6,17-dihydroxy-18,19-dinorpregn-4-en-20-yn-3-one; (+/-)-13-Ethyl-6beta,17-dihydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one;Y643AOR6HN;Levonorgestrel Imp. H (EP); 13-Ethyl-6beta,17-dihydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one; Levonorgestrel Imp. H (Pharmeuropa); 6beta-Hydroxylevonorgestrel; Levonorgestrel Impurity H;(6beta,17alpha)-13-Ethyl-6,17-dihydroxy-18,19-dinorpregn-4-en-20-yn-3-one;18,19-Dinorpregn-4-en-20-yn-3-one, 13-ethyl-6,17-dihydroxy-, (6beta,17alpha)-;LEVONORGESTREL IMPURITY H [EP IMPURITY];18,19-DINORPREGN-4-EN-20-YN-3-ONE, 13-ETHYL-6,17-DIHYDROXY-, (6.BETA.,17.ALPHA.)-;6.BETA.-HYDROXYLEVONORGESTREL;6beta-Hydroxy Norgestrel;55555-97-0;(6.BETA.,17.ALPHA.)-13-ETHYL-6,17-DIHYDROXY-18,19-DINORPREGN-4-EN-20-YN-3-ONE;Levonorgestrel impurity H [EP];6b-Hydroxylevonorgestrel;rac 6b-Hydroxy Norgestrel;G91039;13-ETHYL-6.BETA.,17-DIHYDROXY-18,19-DINOR-17.ALPHA.-PREGN-4-EN-20-YN-3-ONE;Levonorgestrel Impurity H (6-beta-Hydroxy Levonorgestrel);AKOS032958180;6beta-Hydroxylevonorgestrel;13-Ethyl-6beta,17-dihydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one;rac 6beta-Hydroxy Norgestrel |
